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Abstract 
Human cytomegalovirus (HCMV) is a widespread pathogen that is particularly skilled at 
evading immune detection and defense mechanisms, largely due to extensive co-evolution with 
its host’s immune system.  One aspect of this co-evolution involves the acquisition of four virally 
encoded GPCR chemokine receptor homologs, products of the US27, US28, UL33 and UL78 
genes. G protein-coupled receptors (GPCR) are the largest family of cell surface proteins, found 
in organisms from yeast to humans.  In this research, phylogenetic analysis was used to 
investigate the origins of the US27 and US28 genes, which are adjacent in the viral genome. The 
results indicate that both US27 and US28 share the same common ancestor, the gene for human 
chemokine receptor CX3CR1, suggesting that a single human gene was captured and that a viral 
gene duplication event occurred. It also appears that after the gene duplication event, US27 may 
have undergone neofunctionalization, while US28 maintained the function of their ancestral 
gene. While the evolutionary advantage of the gene duplication and neofunctionalization event 
remains unclear, experimental evidence indicates that each gene has evolved distinct, important 
functions during virus infection.  
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Introduction 
Herpes Virus Family Evolution 
Human cytomegalovirus (HCMV) is a herpes virus with the ability to establish life-long 
infection. Widespread throughout the population (1), HCMV is adept at evading the host 
immune system, largely due to having acquired many genes with homology to genes from its 
human host (2). This propensity for dodging the host immune system is a characteristic trait of 
many herpes viruses. Several studies have led to the conclusion that the herpes virus family co-
evolves with its host, typically through gene capture (3-5).  This has led to many independent 
adaptations including the acquisition of HCMV’s US27 and US28 genes, which is only present 
in primate cytomegaloviruses. Herpes viruses benefit from this lateral transfer in two ways. For 
one, lateral transfer provides a mechanism for molecular mimicry, which leads to reduced 
immune detection because the virus has increased host-like proteins that the host immune system 
is less likely to detect (6). Secondly, it acts as a relatively fast way to introduce new genes and 
functions into the viral genome, potentially increasing fitness (4, 5). 
 
Human Cytomegalovirus 
 HCMV rarely causes disease in a fit host, but more frequently, acts as an opportunistic 
pathogen. In healthy individuals, HCMV infection produces a strong immune response involving 
both the innate and adaptive systems. Despite this immune response, even immunocompetent 
hosts are unable to eliminate the virus from latency (7). It is believed that HCMV’s ability to 
perform immunomodulation through chemokine and chemokine receptor homologs plays a role 
in this strong latency protection (7). This research will examine two chemokine receptor 
homologs, the gene products of US27 (pUS27) and US28 (pUS28), that have various functions 
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within the virus, one of which is mediation of the host chemoattraction immune defense strategy 
(7).  
Although the virus can reactivate from latency periodically, hosts typically do not 
experience clinical symptoms due to strong T-cell responses (7, 8). Immunocompromised 
patients, however, are much more likely to experience observable symptoms upon degradation of 
the immune system, with flu-like symptoms often being reported (9). HCMV symptoms 
(malaise, fever, sweats, etc.) may appear minimal, but HCMV infection in an 
immunocompromised patient is extremely serious and often requires hospitalization for 
treatment. Additionally, congenital infection can lead to severe birth defects, including hearing 
loss, mental disability, small head size, seizures, and death (10). 
Recently, HCMV has been connected to increased malignancy of cancers through a 
process known as “oncomodulation” where the virus infects existing tumor cells, leading to 
increased cellular proliferation, chemotaxis, and other malignancy capabilities (11). This ability 
to affect the growth and spread of cancer does not rely on an immune compromised host. 
Oncomodulation properties of HCMV can be seen in glioblastomas, where the virus is capable of 
promoting the malignant phenotype, making the HCMV a potential target when treating 
malignant gliomas (12). It also has been recently discovered that inflammatory breast cancer 
cells have a higher incidence of multiple viral DNAs (including HCMV) than non-inflammatory 
breast cancer cells (13). Human cytomegalovirus, although originally viewed as primarily 
benign, undoubtedly has significant impact on all stages of human life, from gestation with 
congenital birth defects to adulthood with opportunistic attack and oncomodulation. 
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G-Protein-Coupled Receptors (GPCRs)  
This study is focused on US27 and US28, two genes within HCMV that show homology 
to human chemokine receptors, a class of GPCRs (14). Along with the gene products of UL33 
(pUL33) and UL78 (pUL78), these GPCR homologs are key elements in HCMV’s ability to 
establish lifelong latent infection within its host. GPCRs are cell surface receptors, which 
produce a cellular signal or response upon the binding of a ligand. Humans have over 800 unique 
GPCRs, with a wide assortment of roles, yet each is similar in physical structure (15). As seen in 
Figure 1, these receptors are made of a single polypeptide that folds to create seven segments, 
looping in and out of the cell with the N-terminus and C-terminus being extra- and intracellular, 
respectively. Once a ligand activates a GPCR, a conformational change occurs causing it to 
activate a local G-protein, which then leads to the dispatch of signals within the cell. 
 
 
 
 
 
 
 
 
 
 
 
 
 6 
 
 
 
 
 
 
 
Figure 1. GPCR activation in response to ligand binding. Image taken from Rajagopal S. et al., 
2010 (16). 
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pUS27 and pUS28 have homology to human chemokine receptors, a subset of the GPCR 
superfamily, which play a crucial role in immune response. Each chemokine receptor binds to 
specific chemokines, small secreted proteins, and regulates intracellular signaling and immune 
responses (17). Responses to ligand binding and G-protein activation include pro-inflammation 
or anti-inflammation, enhanced chemotaxis, and superoxide anion production (17). Proper 
functioning of these chemokine receptors is key for mediating damage from an infection or 
injury. Moreover, dysregulation of chemokine receptors, chemokines, and chemokine attractants, 
plays a key role in inflammatory and infectious diseases, including psoriasis and allergies (17). 
As summarized by Beisser et al. (2008), the key hallmark features of a chemokine 
receptor homologue include: N-linked glycosylation and multiple negatively charged amino 
acids in the N-terminus, the capability to form a disulfide bond between the N-terminus and third 
extracellular loop, multiple positively charged amino acids in the third intracellular loop, 
conserved amino acids in the transmembrane regions, and many serine and threonine residues in 
the C-terminus (18). In addition to putative chemokine receptors pUS27, pUS28, pUL33 and 
pUL78, HCMV contains several genes that could code for a seven transmembrane region. 
However, only pUS27, pUS28, and pUL33 meet these criteria, with pUS27 and pUS28 showing 
the greatest similarity to chemokine receptors.  
  
US27 and US28 
 This study aims to examine the evolutionary history of HCMV’s US27 and US28, two 
genes that code for human chemokine receptor homologs, currently hypothesized to have arisen 
via gene duplication. In an analysis by Beisser et al. (2002), US27 and US28 showed the closest 
similarity to the human chemokine receptor gene CX3CR1, but the study did not evaluate the 
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evolutionary history of these two genes (19). The goal of this research is to provide a rooted, 
phylogenetic analysis to determine the ancestral origins of US27 and US28. Additionally, 
although these viral proteins have been determined to be homologs of human GPCRs, it is 
unclear what parent gene US27 and US28 came from (18). HCMV, like other herpes viruses, is 
known to use gene duplication and co-evolution with its host as a means of diversifying its 
genome (4). Phylogenetic analysis may indicate whether US27 and US28 evolved independently 
(showing two separate parent genes) or via gene duplication (with one parent gene).  
pUS27 is a putative chemokine receptor, and it has no known ligands to date. 
Furthermore, this protein can be found intracellularly and within the transmembrane region of an 
infected cell (7). It increases the extracellular spread of the HCMV virus by 10-fold in fibroblasts 
and endothelial cells in comparison to a US27 knockout strain (20). pUS27 may be responsible 
for enhancing chemotaxis of virus-infected cells by increasing signaling through CXCR4, a 
human chemokine receptor (21). Additionally, pUS27 has shown to increase cellular 
proliferation in human embryonic kidney cells (HEK293) by suppressing host negative growth 
regulators, although the complete mechanism is unknown (21).  
In contrast to pUS27, pUS28 is a functional chemokine receptor that is known to bind to 
an extensive variety of ligands (22). pUS28 appears to play a key role in HCMV infection 
efficacy and potency along with increased cell-to-cell spread of the HCMV virus (23, 24). 
pUS28 has immunoevasion properties, due to its ability to internalize host chemokines, 
decreasing the host immune system’s capabilities (7, 19). Some chemokines that pUS28 plays a 
role in binding include, but are not limited to: CCL2, CCL4, CCL5, CCL7, and CX3CL1 (7, 25). 
By binding to these chemokines, pUS28 is responsible for limiting their dissemination, 
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interfering with host immune activity (7).  Despite the differences between pUS27 and pUS28, 
both proteins play an important role in the virus’ ability to infect its host.  
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Methods 
 
HCMV Strains 
The US27 and US28 genes come from the AD169, Towne, Toledo, Merlin, TR, and 
TB40/E strains of HCMV, and all of these strains were used for the phylogenetic analysis portion 
of this study. The GenBank accession numbers of these viral genes can be found in Table 1. 
These strains were chosen because they are prominent laboratory strains (AD169, TB40/E, 
Towne) and clinical isolates (Toledo, TR, Merlin) (26, 27). Gross gene alignments were done 
using HCMV’s strain AD169, the first HCMV strain to be sequenced and annotated, which is 
extensively used during laboratory research (26).  
 
Gross Gene Comparison 
The pUS27 and pUS28 amino acid sequences were independently searched through 
GenBank using the NCBI’s protein Basic Local Alignment Search Tool (BLAST). This search 
compared the HCMV gene to the entire humane genome, displaying the top 100 matches by E-
value (28). All unique chemokine receptors from this list of the top 100 matches were compiled 
and used for further analysis. This BLAST tool was also utilized to provide e-values between 
US27, US28 and their closest human chemokine receptor matches. The outgroup used in 
phylogenetic analysis is a human G-protein coupled receptor that is not part of the chemokine 
receptor family. Accession numbers for the human receptors can be found in Table 2. 
 
 
 
 
 11 
 
 
 
 
 
 
 
Table 1. HCMV protein accession numbers for HCMV strains1 
Name Strain Accession Number 
US27 AD169 ABG73076.1 
US27 Towne ABG73086.1 
US27 Toledo AAS49024.1 
US27 Merlin YP_081611.1 
US27 TR AGL96752.1 
US27 TB40/E ABV71517.1 
US28 AD169 ACL51230.1 
US28 Towne ACM48113.1 
US28 Toledo AAS49025.1 
US28 Merlin YP_081612.1 
US28 TR AGL96753.1 
US28 TB40/E ABV71518.1 
1obtained from GenBank. 
 
Table 2. Human GPCR accession numbers1 
Receptor Name Accession Number 
CCR1 NP_001286.1 
CCR4 NP_005499.1 
CCR9 AAH95516.1 
CX3CR1 NP_001328.1 
CCR5 NP_000570.1 
CCR3 NP_001828.1 
CXCR3 NP_001495.1 
CCR6 NP_004358.2 
CCR8 NP_005192.1 
CXCR4 CAA12166.1 
CCR2 AGC02843.1 
Oxoeicosanoid Receptor 12 NP_062545.1 
1Obtained from GenBank. 
2Oxoeicosanoid Receptor 1 is the outgroup used in later phylogenetic analysis.  
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Alignment 
Protein alignments between HCMV strains were performed using the MUSCLE multiple 
sequence alignment tool, version 3.8 (29), and alignment matrices were created by Clustal2.1 
(30, 31) within Geneious v. 9.1, a bioinformatics phylogenetics software, with the default 
settings used (32). The alignments were then further edited by hand to replace blanks at the 
beginning and end of the alignment with missing data question marks.   
 
Phylogenetic Analysis 
Using Geneious v. 9.1, this research inferred phylogenetic trees using Bayesian and 
maximum likelihood method to analyze the evolutionary history of the pUS27 and pUS28 
proteins in relation to select human chemokine receptors. The maximum likelihood analysis was 
inferred using PhyML v. 3.0 plugin  (33, 34) on the Geneious v. 9.1 software. Node values 
display bootstrap values (with 100 replicates) while all other settings utilized the default 
Geneious specifications. The Bayesian phylogenetic analysis was run utilizing the MrBayes 
plugin on Geneious software. A chain length of 10,100,000, subsampling frequency of 2,000, 
and burn-in length of 1,100,00 were used, with all other parameters set to default Geneious 
specifications (35). 
Maximum likelihood estimations determine which tree most likely depicts an accurate 
evolutionary history. Bayesian analysis also examines the likelihood of a given tree based on 
given models of evolution. Parsimony analysis was not used due to its higher sensitivity to long-
branch attraction than either maximum likelihood or Bayesian models (36). 
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Protein Analysis 
 Using GenomeNet’s MOTIF search, this study searched pUS27 and pUS28 in the 
National Center for Biotechnology Information-Conserved Domain Database (NCBI-CDD). The 
ExPASy Bioinformatics Resource Portal was also utilized to search the Prosite database using 
ScanProsite. Both HCMV genes analyzed came from the AD169 strain.  
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Results 
Protein Alignments 
In order to determine which HCMV strain sequence to use for subsequent analyses of 
pUS27 and pUS28, variability among different strains was examined. A Clustal comparison 
matrix is shown in Tables 3 and 4. Here, it is observable that the 6 strains examined in this study 
show minimal variation within the pUS27 and pUS28 primary protein structure. The pUS28 
comparisons are displayed in Table 3, where it is shown that the lowest percent identity is 
between the strains TB40 and TR (both clinical strains) with 97.46% identity match within the 
pUS28 primary protein structure. The closest identity is seen between AD169 and Towne, both 
laboratory strains that share 100% identity match within the pUS28 protein. Table 4 shows 
pUS27 percent identity comparisons, where there is slightly more variation between strains. The 
highest variation is between TB40/E and Merlin, a laboratory and clinical strain respectively, 
with 94.74% identity match within the pUS27 protein. The closest similarity is again seen 
between Towne and AD169 where they show 95.58% identity match within the pUS27 protein. 
Thus, both genes are highly conserved among distinct virus strains, indicating their function is 
likely beneficial for the virus.  
 
 
 
 
 
 
 
 
 15 
 
 
 
 
 
 
 
 
 
 
 
Table 3. HCMV pUS28 alignment percent identity matrix.1  
 TB40/E TR Toledo AD169 Towne Merlin 
TB40/E 100.00 97.46 98.02 98.31 98.31 98.02 
TR 97.46 100.00 99.44 98.87 98.87 98.59 
Toledo 98.02 99.44 100.00 99.44 99.44 99.15 
AD169 98.31 98.87 99.44 100.00 100.00 99.72 
Towne 98.31 98.87 99.44 100.00 100.00 99.72 
Merlin 98.02 98.59 99.15 99.72 99.72 100.00 
1Alignment performed using the MUSCLE multiple sequence alignment tool, version 3.8 (29). 
Matrix created using Clustal2.1 formatting. 
 
 
 
 
Table 4. HCMV pUS27 alignment percent identity matrix. 1 
 TB40/E TR Toledo AD169 Towne Merlin 
TB40/E 100.00 98.06 95.29 98.34 95.29 94.74 
TR 98.06 100.00 95.30 99.17 95.30 95.30 
Toledo 95.29 95.30 100.00 95.58 99.45 98.90 
AD169 98.34 99.17 95.58 100.00 95.58 95.03 
Towne 95.29 95.30 99.45 95.58 100.00 98.90 
Merlin 94.74 95.30 98.90 95.03 98.90 100.00 
1Alignment performed using the MUSCLE multiple sequence alignment tool, version 3.8 (29). 
Matrix created using Clustal2.1 formatting. 
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Figures 2 and 3 display the closest chemokine receptors to pUS27 and pUS28, 
respectively. Alignments between complete primary protein structures were evaluated using e-
value. Figures 2-4 use the reciprocal e-value in order to show a clear visualization of a larger bar 
equating to a closer alignment match. Figure 2 shows that pUS27 shares the highest similarity 
with CCR1, although the difference between E-values for alignments of pUS27 with CCR1 and 
pUS27 with CCR4 (the second most closely matched to pUS27) are not extraordinarily different.  
pUS28 on the other hand, shows a very strong correlation to CX3CR1 in particular. The 
difference in alignments between pUS28 and CX3CR1 and CCR4 (the second most closely 
matched to US27) is very significant. As seen in Figure 4, the alignment of pUS27 and pUS28 
results in an e-value of 1E-49. This shows that pUS27 is closer to pUS28 than any human 
chemokine receptor; however, pUS28 is closer to CX3CR1 than pUS27. 
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Figure 2. US27’s closest chemokine receptor matches, displaying reciprocal e-value for 
alignment results from BLASTp results after searching pUS27 and accumulating the closest 
chemokine receptor matches (28).  
 
Figure 3. US28’s closest chemokine receptor matches, displaying reciprocal e-value for 
alignment results from BLASTp results after searching pUS27 and accumulating the closest 
chemokine receptor matches (28). 
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Figure 4. Comparison of pUS27 and pUS28 closest alignment matches in addition to added 
alignment of pUS27 and pUS28. 
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Phylogenetic Analysis 
Phylogenetic analysis was used to determine if US27 and US28 do or do not share a 
common ancestor. A common ancestor would indicate a shared evolutionary history with the two 
genes evolving via a gene duplication event. If US27 and US28 had separate ancestral genes, 
then it is more likely that the two genes evolved via two separate gene captures between HCMV 
and the host DNA 
Figure 5 displays a maximum likelihood model phylogeny, which supports the hypothesis 
that US28 and US27 share a common ancestor. Additionally, the common ancestor of these two 
viral genes shares a common ancestor with human CX3CR1. Here, the bootstrap support values 
show strong support for a common ancestor between pUS27 and pUS28. There is very minimal 
support, however, towards pCX3CR1 being the closest human protein to pUS27 and pUS28’s 
common ancestor. The Bayesian phylogenetic analysis in Figure 6 concurs with the maximum 
likelihood phylogeny, showing a common ancestral gene between US28 and US27 with that viral 
ancestral gene sharing a common ancestral gene with human CX3CR1. The posterior 
probabilities are extremely supportive of both US27 and US28’s common ancestor and this 
common ancestor’s relationship to CX3CR1. These results suggest that a gene capture event led 
to the common ancestor of US28 and US27 within the HCMV virus. Then, within the HCMV 
virus, there was another gene duplication event that led to US28 and US27 evolving from one 
common ancestor. Using Bayesian and maximum likelihood phylogeny, it was determined that 
US27 and US28 most likely arose from a gene duplication event, and their closest human 
ancestor gene is CX3CR1. 
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Figure 5. Maximum likelihood phylogenetic tree of human chemokine receptors and pUS27 and 
pUS28. Nodes values display bootstrap values (100 replicates). Inferred using PhyML and 
Geneious v 8.1.3 (33). 
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Figure 6. Bayesian phylogenetic tree of human chemokine receptors and pUS27 and pUS28. 
Node values display posterior probabilities.  Inferred using MrBayes and Genious v 8.1.3 (35).  
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Protein Analysis 
When analyzing pUS27 and pUS28 using the Prosite protein database (37), both pUS27 
and pUS28 showed GPCR similarities (due to their seven transmembrane hydrophobic regions), 
and their N-terminal and C-terminal domains showed no statistically significant motifs. Although 
both pUS27 and pUS28 contain sites for cAMP- and cGMP-dependent protein kinase 
phosphorylation, N-myristoylation, N-glycosylation, and Casein kinase II phosphorylation, these 
motifs are not considered significant due to their “high probability of occurrence” (37). They are 
motifs that are found in many proteins, frequently enabling post-translational modification.  
Hydrophobicity plots of CX3CR1, pUS27, and pUS28 can be found in Figures 7, 8, and 9 
respectively. Here, the 7 regions of hydrophobicity correlating to the 7 transmembrane regions of 
each of these proteins can be observed. These transmembrane regions are sites of amino acid 
similarity between all GPCRs due to the limited number of hydrophobic amino acids and 
conserved nature of the GPCR structure. Even so, US27 and US28 displayed a closer 
evolutionary history to CX3CR1, as seen in Figures 5 and 6. These hydrophobicity plots are 
important for determining the intracellular, extracellular, and transmembrane regions of the 
protein. A future extension of this project should examine which segments are constrained within 
the transmembrane regions, compared to the intracellular and extracellular regions. It is expected 
that the transmembrane regions will have a lower amino acid substitution rate, while the 
intracellular and extracellular regions will have a higher amino acid substitution rate. 
Extracellularly, an increased amino acid substitution rate will allow the receptors to bind to 
different chemokines. Intracellular changes in the primary protein structure could allow for 
variations in cell signaling pathways. In short, examining the hydrophobic regions of the 
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CX3CR1, pUS27, and pUS28 will provide insight into the significant differences between these 
receptors.   
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Figure 7. CX3CR1 hydrophobicity plot built utilizing the Kyte and Doolittle amino acid scale 
(38) and the ProtScale software (39). 
 
 
 
 
 
 
 
Figure 8. pUS27 hydrophobicity plot built utilizing the Kyte and Doolittle amino acid scale (38) 
and the ProtScale software (39). 
 
 
 
 
 
 
 
Figure 9. pUS28 hydrophobicity plot built utilizing the Kyte and Doolittle amino acid scale (38) 
and the ProtScale software (39). 
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Discussion 
Although the evolutionary history of viruses is difficult to determine due to significant 
variation between strains and high rates of mutation, this evidence points towards the conclusion 
of a gene duplication leading to the presence of the US27 and US28 genes in HCMV. It is likely 
that an ancestral HCMV captured CX3CR1 from its human host, then integrated this gene into its 
own genome. This newly integrated gene would have then undergone a gene duplication event 
which led to the creation US27 and US28. Some of the numerous possible outcomes of a gene 
duplication are displayed in Figure 10.  
Labeled “b,” neofunctionalization occurs when one gene from a gene duplication lacks 
selective pressure, while the other gene is constrained by it (40). In the neofunctionalization 
scenario, one protein has a low amino acid substitution rate due to purifying selection pressure, 
causing it to stay much more similar to its parent gene. On the other hand, the second gene may 
take on a new function because of the lack of selective pressure (41). Subfunctionalization, 
labeled “c” in Figure 10, occurs when there is no evolutionary advantage to the extra gene copy 
(41). With a lack of selective pressure, both genes can mutate, while keeping complementary 
functions of the original genes. This can be an important form of evolution, because it allows 
enhanced evolution of specific aspects of a gene without trading off fitness for other aspects of a 
gene.  
Because pUS28 shows a much higher similarity to pCX3CR1 than pUS27 (as seen in 
Figure 4), it is likely that US27 underwent neofunctionalization after divergence, although 
subfunctionalization is also a possibility. With this model, it is proposed that after gene 
duplication occurred, the virus was able to keep the functionality of pUS28, while pUS27 could 
be less constrained and eventually gain a new function.  Other outcomes for duplicated genes 
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include gene loss (Fig. 10a) or regulatory differentiation (Fig. 10d) (42). Although regulatory 
differentiation could have occurred, it is not the focus of this research. Since regulatory 
sequences are not transcribed into mRNA, the protein amino acid sequences examined in this 
research is not sufficient for examining the differences between US27 and US28’s regulatory 
patterns (41).  What can be concluded from this research is that pUS27 likely underwent 
neofunctionalization after a gene duplication event while US28 had a lower amino acid 
substitution rate, keeping its original function. Further research should examine the intracellular 
and extracellular regions of pUS27, pUS28, and CX3CR1. If the neofunctionalization model is 
correct, then pUS28 should show closer similarity to CX3CR1 in these regions, because it was 
more conserved after the gene duplication event than pUS27. Further analysis could confirm 
whether neofunctionalization is the most likely outcome of the US27/US28 gene duplication.  
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Figure 10. Representation of the possible fates of a duplicated gene. Image taken from Louis, 
2007 (42). 
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Both maximum likelihood and Bayesian phylogenetic hypotheses a common ancestor 
between US27 and US28, suggesting a gene duplication event led to their existence. Their 
closest human ancestral gene appears to be Chemokine (C-X3-C Motif) Receptor 1 (CX3CR1). 
The effectiveness of these methods can be observed when examining the clades containing 
CCR1, CCR2, CCR3, CCR4, CCR5, and CCR8 in Figures 5 and 6. Five out of six of these 
proteins are coded for on Chromosome 3, likely suggesting that they share an evolutionary 
history. The fact that they were grouped together in both the Maximum Likelihood and Bayesian 
phylogenies corroborates that these methods are successful at grouping together proteins that 
share evolutionary history. 
The CX3CR1 gene, located on Chromosome 3, codes for a chemokine receptor that binds 
fractalkine, also known as CX3C Ligand 1. Activation of the CX3CR1 protein leads to mediation 
ofthe cell’s adhesion and movement functions (43). This receptor is largely associated with 
expression on lymphocytes, but CX3CR1 has also been observed in leukocytes and migroglial 
cells (44). In the central nervous system, CX3CR1 and CX3CL1 play an important role, and the 
binding of fractalkine to CX3CR1 leads to the attraction of intraepithelial lymphocytes (45). 
Additionally, fractalkine contributes to immune function by stimulating the migration of 
leukocytes during both physiological and pathological conditions. This ligand can exist as either 
a membrane bound or isolated soluble protein (46). When it is in a soluble state, it serves an 
important role as chemoattractant for the CD8+ and CD4+ T cells, natural killer cells, and 
monocytes that express the CX3CR1 receptor. In a membrane-bound state, fractalkine and 
CX3CR1 form strong binding interactions (46).  
 29 
The human gene CX3CR1 contains 4 exons and 3 introns, displayed in Figure 11 (47). 
On the other hand, US27 and US28 do not contain any introns (48). In this figure, the DNA of 
CX3CR1 is shown with 3 introns, surrounded by 4 exons, while the processed mRNA only 
contains the 4 exons. This is important to note, because the exact mechanism of gene capture has 
not been determined; however, since US27 and US28 do not contain introns, it is possible that 
HCMV gained the common ancestor to US27 and US28 from a retrovirus genome during a 
mixed infection (49). Further research could experimentally determine if HCMV is capable of 
gaining genetic information from a retrovirus during the co-infection of a cell.  
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Figure 11. Representation of CX3CR1 gene displaying exons and introns compared to mature 
CX3CR1 mRNA 
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One disease commonly associated with CX3CR1 is human immunodeficiency virus 
infection and its progression to acquired immune deficiency syndrome (HIV/AIDS). CX3CR1 is 
a co-receptor for HIV-1, and some variations of the gene have been linked to an increase in 
susceptibility of infection of HIV and rapid progression of HIV infection to AIDS (50). There are 
also increased levels of expression of the CX3CR1 within HIV-positive monocytes (51). 
Moreover, active HCMV infection in HIV-infected patients has been connected with perpetually 
low CD4+ T cell counts (52).  It’s possible that HCMV co-infection is an increased risk factor 
for the progression of HIV to AIDS, because pUS28 has similar binding properties to CX3CR1. 
In fact, US28 has been identified as a co-receptor for HIV, and HCMV has been connected to 
HIV’s disease progression to AIDS (52, 53). There is certainly a noteworthy connection between 
pUS27 and pUS28, whose ancestral protein is CX3CR1, and the role of HCMV in the 
progression of HIV-infection to AIDS. 
Recent research has also shown a functional role of CX3CR1 in the metastasis of breast 
cancer, while inhibition of the receptor impairs breast cancer cells’ ability to seed in their host 
(54). Furthermore, primary breast cancer tumors have shown to overexpress CX3CR1 (54). Our 
research has shown that US27 and US28 likely evolved from a CX3CR1 homolog. Again, if 
pUS27 and pUS28 express similar binding properties to CX3CR1, they may be creating the same 
cellular signaling pathways that cause CX3CR1 to play a role in the metastasis of breast cancer. 
Although this has not been experimentally proven, it is a hypothesis that should be explored 
further, because it provides an explanation for HCMV’s link to the metastasis of patients with 
primary breast cancers (55, 56).  
The US27 gene is only found in primate CMV strains. Additionally, a gene duplication 
event with US28 homologs has been documented within RhCMV, where there are five copies of 
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the US28 homolog, Rh214, Rh215, Rh216, Rh218, and Rh220 (57). Further research should 
examine the evolutionary advantage of these 5 copies, potentially shedding light on US27’s 
function within HCMV. Another strategy to examine pUS27 should include comparative 
analyses between US27/pUS27 and other mammal CMV genomes and proteomes. Identifying 
common motifs, especially within the N- or C-terminal domains, could indicate pUS27’s role 
within HCMV. Understanding the role pUS27 and pUS28 have in ensuring the success of 
HCMV infection and proliferation can shed light on their function within the progression of 
diseases such as HIV/AIDS and cancer. It also furthers research regarding potential antiviral 
targets in treating such disease.  
Although the binding and signaling mechanisms of pUS27 remain unclear, there is no 
doubt that both pUS27 and pUS28 have a fundamental role in the functioning, infection, and 
spread of HCMV. BLAST searching and alignment features were able to elucidate the closest 
human chemokine receptor proteins to pUS27 and pUS28, while phylogenetic analyses 
examined the evolutionary history. Here, this research found that a gene capture event likely 
occurred between CMV and its host, along with an intermediate retrovirus. The gene captured in 
this event became the common ancestor of US27 and US28. From there, neofunctionalization 
occurred, leaving pUS28 with a similar function to its common ancestor and pUS27 with a new 
function that research has yet to fully elucidate. Further research should focus on elucidating the 
differences between pUS27 and pUS28, particularly within intracellular and extracellular regions 
of the amino acid code, where the most meaningful variation is likely to occur. The impact of 
this research includes identifying key components to HCMV function that could be targeted in 
antiviral therapies. These therapies could treat a myriad of diseases that HCMV plays a role in 
aggravating, including breast cancer and HIV/AIDS.  
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